Delivery Order SPE2DB25D3020-SPE2DB25FWKNX
Award Date 9/11/25
Potential Completion Date 9/12/25
Potential Value $18K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,286.99 to AmerisourceBergen Drug Corp for 120 tablets of Mesalamine DR 1.2 GM on August 15, 2025, with completion targeted for August 18, 2025. This firm fixed price delivery order represents a non-set-aside award issued under competitive procurement procedures. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,993.43 to AmerisourceBergen Drug Corp for Mesalamine DR 400 mg capsules (180 count) on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract for pharmaceutical supply to support federal medical procurement needs. The product will be performed and delivered from AmerisourceBergen's corporate office located in...
- The Defense Logistics Agency awarded a delivery order valued at $3,841.26 to AmerisourceBergen Drug Corp for Mesalamine ER 0.375 gram capsules (120-count supply). This is a firm fixed price contract with no set-aside designation, awarded on August 14, 2025, with an ultimate completion date of August 15, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location. Mesalamine is a gastrointestinal anti-inflammatory medication used to treat conditions such as...
- The Defense Logistics Agency awarded a delivery order valued at $1,083.24 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count). This is a firm fixed-price delivery order with a completion date of September 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Mesalamine ER 0.375 gram capsules (120-count). This is a firm fixed price delivery order with a ceiling value of $7,754.63 and an ultimate completion date of September 9, 2025. The award represents a non-competitive procurement and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $5,414.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count units). This is a non-set-aside, competitively awarded contract with an ultimate completion date of July 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,986.08 on September 8, 2025, for the supply of Mesalamine 800 mg delayed-release tablets (180-count units). This is a firm fixed-price, non-set-aside contract with performance to be completed by September 9, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. Mesalamine is a medication used to treat inflammatory bowel conditions, representing a routine...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Mesalamine DR 1.2 GM tablets in quantities of 60 units. This is a firm fixed-price delivery order with a ceiling value of $1,556.04, with an ultimate completion date of September 4, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $6,684.66 to AmerisourceBergen Drug Corp for 180 capsules of Mesalamine 400 mg, a medication commonly used to treat inflammatory bowel conditions. The contract is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, and was competitively awarded without any set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,059,712 units of the medication Mesalamine DR 400 mg capsule in 180-count bottles. The delivery order, valued at $15,721.70, has a firm fixed-price pricing type and an ultimate completion date of April 29, 2025. This award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) held by...